Real-time enrollment status for this recurrent atypical teratoid/rhabdoid tumor clinical trial
Current Status
Recruiting
Checked: October 19, 2026 at 3:24 PM UTC
| NCT Number | NCT07447076 |
| Recruiting Status | Recruiting |
| Condition | Recurrent Atypical Teratoid/Rhabdoid Tumor |
| Phase | PHASE2 |
| Target Enrollment | 29 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Sabine Mueller, MD, PhD |
| Last Updated on CT.gov | June 23, 2026 (Jun 23, 2026) |
As of October 19, 2026: Clinical trial NCT07447076 is currently recruiting participants. This phase2 study for recurrent atypical teratoid/rhabdoid tumor is actively seeking new participants at 2 locations across the United States. The study is sponsored by Sabine Mueller, MD, PhD. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07447076 is actively recruiting participants as of October 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07447076 was last updated Jun 23, 2026 (June 23, 2026). HelloStudys verifies this status automatically.